{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:21:17Z","timestamp":1790713277871,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Augusta University Medical Center"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jss.2019.06.010","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T18:02:06Z","timestamp":1570816926000},"page":"260-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy"],"prefix":"10.1016","volume":"246","author":[{"given":"Erika","family":"Simmerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2019.06.010_bib1","doi-asserted-by":"crossref","first-page":"9137","DOI":"10.1007\/s13277-015-4126-3","article-title":"Harnessing the immunomodulatory effect of thermal and non-thermal ablative therapies for cancer treatment","volume":"36","author":"Bastianpillai","year":"2015","journal-title":"Tumor Biol"},{"key":"10.1016\/j.jss.2019.06.010_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.tvir.2015.06.002","article-title":"Introduction to irreversible electroporation \u2013 principles and techniques","volume":"18","author":"Thomson","year":"2015","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.jss.2019.06.010_bib3","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/jso.23280","article-title":"Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures","volume":"107","author":"Cannon","year":"2013","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jss.2019.06.010_bib4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1515\/raon-2015-0031","article-title":"Careful treatment planning enables safe ablation of liver tumors adjacent to major blood vessels by percutaneous irreversible electroporation","volume":"49","author":"Kos","year":"2015","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.jss.2019.06.010_bib5","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/1097-0142(19810301)47:5<1005::AID-CNCR2820470532>3.0.CO;2-9","article-title":"The effect of the anatomic setting on the results of surgical procedures for soft parts sarcoma of the thigh","volume":"47","author":"Enneking","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2019.06.010_bib6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00003086-198011000-00013","article-title":"A system for surgical staging of musculoskeletal sarcoma","author":"Enneking","year":"1980","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.jss.2019.06.010_bib7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/SLA.0000000000001441","article-title":"Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation","volume":"262","author":"Martin","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2019.06.010_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/j.tvir.2015.06.003","article-title":"Irreversible electroporation in the treatment of hepatocellular carcinoma","volume":"18","author":"Lencioni","year":"2015","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.jss.2019.06.010_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/j.tvir.2015.06.007","article-title":"Irreversible electroporation for colorectal liver metastases","volume":"18","author":"Scheffer","year":"2015","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.jss.2019.06.010_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4329\/wjr.v7.i10.306","article-title":"Locoregional treatment for hepatocellular carcinoma: the best is yet to come","volume":"7","author":"Kalra","year":"2015","journal-title":"World J Radiol"},{"key":"10.1016\/j.jss.2019.06.010_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.hpb.2016.11.001","article-title":"Systematic review on the treatment of isolated local recurrence of pancreatic cancer after surgery; re-resection, chemoradiotherapy, and SBRT","volume":"19","author":"Groot","year":"2017","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jss.2019.06.010_bib12","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.gassur.2006.08.018","article-title":"1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience","volume":"10","author":"Winter","year":"2006","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jss.2019.06.010_bib13","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1245\/s10434-015-5034-x","article-title":"Single-institution experience with irreversible electroporation for T4 pancreatic cancer: first 50 patients","volume":"23","author":"Kluger","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2019.06.010_bib14","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.hpb.2018.12.004","article-title":"A prospective, multi-institution assessment of irreversible electroporation for treatment of locally advanced pancreatic adenocarcinoma: initial outcomes from the AHPBA pancreatic registry","volume":"21","author":"Holland","year":"2019","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jss.2019.06.010_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000367740","article-title":"Recent advances in tumor ablation for hepatocellular carcinoma","volume":"4","author":"Kang","year":"2015","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jss.2019.06.010_bib16","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1038\/srep16233","article-title":"Electric ablation with irreversible electroporation (IRE) in vital hepatic structures and follow-up investigation","volume":"5","author":"Chen","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jss.2019.06.010_bib17","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1158\/0008-5472.CAN-09-3067","article-title":"Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma","volume":"70","author":"Guo","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2019.06.010_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3892\/mco.2013.229","article-title":"Local recurrence of hepatocellular carcinoma in the tumor blood drainage area following radiofrequency ablation","volume":"2","author":"Hirooka","year":"2014","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.jss.2019.06.010_bib19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jvir.2015.02.001","article-title":"Factors associated with short-term local recurrence of liver cancer after percutaneous ablation using irreversible electroporation: a prospective single-center study","volume":"26","author":"Niessen","year":"2015","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jss.2019.06.010_bib20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3748\/wjg.v4.i6.527","article-title":"Study on the causes of local recurrence of rectal cancer after curative resection: analysis of 213 cases","volume":"4","author":"Hong-Yin","year":"1998","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jss.2019.06.010_bib21","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-2005-916279","article-title":"Surgical management of locally advanced and locally recurrent colon cancer","volume":"18","author":"Landmann","year":"2005","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1016\/j.jss.2019.06.010_bib22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jamcollsurg.2012.04.029","article-title":"Ablation of perivascular hepatic malignant tumors with irreversible electroporation","volume":"215","author":"Kingham","year":"2012","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jss.2019.06.010_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases","volume":"230","author":"Fong","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2019.06.010_bib24","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/bjc.2014.21","article-title":"Long-term outcome after local recurrence of soft tissue sarcoma: a retrospective analysis of factors predictive of survival in 135 patients with locally recurrent soft tissue sarcoma","volume":"110","author":"Daigeler","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jss.2019.06.010_bib25","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1007\/s11999-010-1481-7","article-title":"Local recurrence after initial multidisciplinary management of soft tissue sarcoma: is there a way out?","volume":"468","author":"Abatzoglou","year":"2010","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.jss.2019.06.010_bib26","doi-asserted-by":"crossref","first-page":"e48749","DOI":"10.1371\/journal.pone.0048749","article-title":"Immunologic response to tumor ablation with irreversible electroporation","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jss.2019.06.010_bib27","doi-asserted-by":"crossref","first-page":"e64559","DOI":"10.1371\/journal.pone.0064559","article-title":"Improved local and systemic anti-tumor efficacy for irreversible electroporation in immunocompetent versus immunodeficient mice","volume":"8","author":"Neal","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jss.2019.06.010_bib28","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00270-014-0988-9","article-title":"Vessel patency post irreversible electroporation","volume":"37","author":"Narayanan","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jss.2019.06.010_bib29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1053\/j.tvir.2015.06.009","article-title":"Irreversible electroporation of hepatic and pancreatic malignancies: radiologic-pathologic correlation","volume":"18","author":"Gonzalez-Beicos","year":"2015","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.jss.2019.06.010_bib30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/SLA.0000000000001731","article-title":"Pancreatic cancer surgery: the new R-status counts","volume":"265","author":"Strobel","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2019.06.010_bib31","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jso.24123","article-title":"The importance of surgical margins in primary malignancies of the liver","volume":"113","author":"Lafaro","year":"2015","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jss.2019.06.010_bib32","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/codi.12960","article-title":"Significance of R1 resection margin in colon cancer resections in the modern era","volume":"17","author":"Khan","year":"2015","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.jss.2019.06.010_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13014-017-0769-0","article-title":"Significant benefits in survival by the use of surgery combined with radiotherapy for retroperitoneal soft tissue sarcoma","volume":"12","author":"Hager","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jss.2019.06.010_bib34","author":"Singh"},{"key":"10.1016\/j.jss.2019.06.010_bib35","series-title":"Chapter 2-Models for Assessing Anti-Angiogenesis Agents: Appraisal of Current Techniques. Anti-Angiogenesis Strategies in Cancer Therapeutics","first-page":"21","author":"Mousa","year":"2017"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002248041930397X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002248041930397X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T14:48:16Z","timestamp":1758379696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002248041930397X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":35,"alternative-id":["S002248041930397X"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2019.06.010","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2019.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}